Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Nevro Corp. stock logo
NVRO
Nevro
$5.85
+0.1%
$5.85
$3.17
$10.37
$224.32M0.81807,130 shs753,602 shs
Avita Medical Inc. stock logo
RCEL
Avita Medical
$5.43
+1.9%
$5.90
$4.71
$14.16
$143.52M1.52191,715 shs171,796 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$8.66
-0.7%
$9.07
$8.15
$22.40
$241.16M2.07187,227 shs200,516 shs
Zynex Inc. stock logo
ZYXI
Zynex
$2.35
+3.5%
$2.32
$1.66
$10.62
$71.06M0.83175,072 shs85,768 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Nevro Corp. stock logo
NVRO
Nevro
0.00%0.00%0.00%0.00%-42.06%
Avita Medical Inc. stock logo
RCEL
Avita Medical
-0.37%-5.33%-2.56%-42.13%-48.75%
ZimVie Inc. stock logo
ZIMV
ZimVie
-1.36%-8.11%-5.11%-7.14%-54.42%
Zynex Inc. stock logo
ZYXI
Zynex
-0.44%-5.02%-4.22%+4.13%-77.30%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Nevro Corp. stock logo
NVRO
Nevro
N/AN/AN/AN/AN/AN/AN/AN/A
Avita Medical Inc. stock logo
RCEL
Avita Medical
1.3743 of 5 stars
3.40.00.00.02.70.00.6
ZimVie Inc. stock logo
ZIMV
ZimVie
2.3429 of 5 stars
3.32.00.00.02.71.70.6
Zynex Inc. stock logo
ZYXI
Zynex
2.2087 of 5 stars
3.20.00.00.02.31.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Nevro Corp. stock logo
NVRO
Nevro
1.92
Reduce$5.36-8.29% Downside
Avita Medical Inc. stock logo
RCEL
Avita Medical
2.75
Moderate Buy$16.50203.87% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.67
Moderate Buy$16.3388.61% Upside
Zynex Inc. stock logo
ZYXI
Zynex
2.33
Hold$5.50134.04% Upside

Current Analyst Ratings Breakdown

Latest ZYXI, ZIMV, RCEL, and NVRO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/15/2025
Zynex Inc. stock logo
ZYXI
Zynex
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$4.00 ➝ $3.00
6/30/2025
Zynex Inc. stock logo
ZYXI
Zynex
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
6/6/2025
Avita Medical Inc. stock logo
RCEL
Avita Medical
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$19.00
5/15/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $10.00
4/30/2025
Zynex Inc. stock logo
ZYXI
Zynex
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$5.00 ➝ $4.00
4/30/2025
Zynex Inc. stock logo
ZYXI
Zynex
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $8.00
(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Nevro Corp. stock logo
NVRO
Nevro
$408.52M0.55N/AN/A$8.10 per share0.72
Avita Medical Inc. stock logo
RCEL
Avita Medical
$64.25M2.23N/AN/A$0.17 per share31.94
ZimVie Inc. stock logo
ZIMV
ZimVie
$443.55M0.54$1.82 per share4.76$13.83 per share0.63
Zynex Inc. stock logo
ZYXI
Zynex
$172.40M0.41$0.25 per share9.34$1.12 per share2.10
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Nevro Corp. stock logo
NVRO
Nevro
-$92.21M-$3.05N/AN/AN/A-16.54%-23.52%-10.83%8/4/2025 (Estimated)
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$61.85M-$2.19N/AN/AN/A-79.61%-632.62%-71.72%8/6/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.71N/AN/A-4.40%5.53%2.84%7/31/2025 (Estimated)
Zynex Inc. stock logo
ZYXI
Zynex
$2.99M-$0.24N/A5.00N/A-4.30%-23.70%-6.23%7/23/2025 (Estimated)

Latest ZYXI, ZIMV, RCEL, and NVRO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$0.26N/AN/AN/AN/AN/A
7/31/2025Q2 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.2285N/AN/AN/A$112.82 millionN/A
7/23/2025Q2 2025
Zynex Inc. stock logo
ZYXI
Zynex
-$0.20N/AN/AN/A$27.38 millionN/A
5/8/2025Q1 2025
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$0.39-$0.53-$0.14-$0.53$33.15 million$18.51 million
5/8/2025Q1 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.21$0.27+$0.06-$0.05$113.10 million$112.00 million
4/28/2025Q1 2025
Zynex Inc. stock logo
ZYXI
Zynex
-$0.24-$0.33-$0.09-$0.33$30.83 million$26.58 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Nevro Corp. stock logo
NVRO
Nevro
N/AN/AN/AN/AN/A
Avita Medical Inc. stock logo
RCEL
Avita Medical
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
Zynex Inc. stock logo
ZYXI
Zynex
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Nevro Corp. stock logo
NVRO
Nevro
0.67
5.02
3.76
Avita Medical Inc. stock logo
RCEL
Avita Medical
9.39
2.09
1.72
ZimVie Inc. stock logo
ZIMV
ZimVie
0.58
2.14
1.48
Zynex Inc. stock logo
ZYXI
Zynex
2.87
3.46
2.63

Institutional Ownership

CompanyInstitutional Ownership
Nevro Corp. stock logo
NVRO
Nevro
95.52%
Avita Medical Inc. stock logo
RCEL
Avita Medical
27.66%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%
Zynex Inc. stock logo
ZYXI
Zynex
29.68%

Insider Ownership

CompanyInsider Ownership
Nevro Corp. stock logo
NVRO
Nevro
3.20%
Avita Medical Inc. stock logo
RCEL
Avita Medical
2.80%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
Zynex Inc. stock logo
ZYXI
Zynex
49.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
Nevro Corp. stock logo
NVRO
Nevro
1,09038.37 million36.27 millionOptionable
Avita Medical Inc. stock logo
RCEL
Avita Medical
13026.43 million25.70 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77027.85 million27.01 millionOptionable
Zynex Inc. stock logo
ZYXI
Zynex
77030.24 million15.34 millionOptionable

Recent News About These Companies

Zynex (ZYXI) to Release Quarterly Earnings on Wednesday
Zynex: New CEO Steven Dyson shares his vision – ICYMI
Zynex: New CEO Steven Dyson shares his vision – ICYMI
Tricare Temporary Payment Suspension Update
Zynex appoints Steven Dyson as new CEO
Zynex taps Steve Dyson as chief executive officer
Zynex Announces Steven Dyson as New CEO
Zynex Announces Workforce Reduction
Here’s Why Zynex (ZYXI) Fell in Q1

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Nevro stock logo

Nevro NYSE:NVRO

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.

Avita Medical stock logo

Avita Medical NASDAQ:RCEL

$5.43 +0.10 (+1.88%)
Closing price 04:00 PM Eastern
Extended Trading
$5.43 0.00 (0.00%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$8.66 -0.06 (-0.69%)
Closing price 04:00 PM Eastern
Extended Trading
$8.66 +0.00 (+0.06%)
As of 05:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

Zynex stock logo

Zynex NASDAQ:ZYXI

$2.35 +0.08 (+3.52%)
Closing price 04:00 PM Eastern
Extended Trading
$2.40 +0.04 (+1.91%)
As of 07:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.